These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1878109)

  • 21. Strategies for the design and synthesis of boronated nucleic acid and protein components as potential delivery agents for neutron capture therapy.
    Wyzlic IM; Tjarks W; Soloway AH; Anisuzzaman AK; Rong FG; Barth RF
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1203-13. PubMed ID: 8175406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
    Ruh TS; Baudendistel LJ
    Endocrinology; 1977 Feb; 100(2):420-6. PubMed ID: 832632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutral and polyanionic carboranylporphyrazines: synthesis and physico-chemical properties.
    Pietrangeli D; Ricciardi G
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S97-S100. PubMed ID: 19375333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. (S)-(+)-4-[7-(2,2-dimethyl-1-oxopropoxy)-4-methyl-2-[4-[2-(1-piperidinyl)-ethoxy]phenyl]-2H-1-benzopyran-3-yl]-phenyl 2,2-dimethylpropanoate (EM-800): a highly potent, specific, and orally active nonsteroidal antiestrogen.
    Gauthier S; Caron B; Cloutier J; Dory YL; Favre A; Larouche D; Mailhot J; Ouellet C; Schwerdtfeger A; Leblanc G; Martel C; Simard J; Mérand Y; Bélanger A; Labrie C; Labrie F
    J Med Chem; 1997 Jul; 40(14):2117-22. PubMed ID: 9216828
    [No Abstract]   [Full Text] [Related]  

  • 25. Boronated protohaemins: synthesis and in vivo antitumour efficacy.
    Ol'shevskaya VA; Nikitina RG; Zaitsev AV; Luzgina VN; Kononova EG; Morozova TG; Drozhzhina VV; Ivanov OG; Kaplan MA; Kalinin VN; Shtil AA
    Org Biomol Chem; 2006 Oct; 4(20):3815-21. PubMed ID: 17024289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Boron-containing chlorins and tetraazaporphyrins: synthesis and cell uptake of boronated pyropheophorbide a derivatives.
    Ratajski M; Osterloh J; Gabel D
    Anticancer Agents Med Chem; 2006 Mar; 6(2):159-66. PubMed ID: 16529538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of two estrogen-responsive proteins by antiestrogens in R27, a tamoxifen-resistant clone of MCF7 cells.
    Vignon F; Lippman ME; Nawata H; Derocq D; Rochefort H
    Cancer Res; 1984 May; 44(5):2084-8. PubMed ID: 6713400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Translocation of cytoplasmic estrogen receptors to the nucleus: immunohistochemical demonstration utilizing rabbit antibodies to estrogen receptors of mammary carcinomas.
    Raam S; Richardson GS; Bradley F; MacLaughlin D; Sun L; Frankel F; Cohen JL
    Breast Cancer Res Treat; 1983; 3(2):179-99. PubMed ID: 6351951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential inhibition of estrogen and antiestrogen binding to the estrogen receptor by diethylpyrocarbonate.
    Borgna JL; Scali J
    J Steroid Biochem; 1988 Oct; 31(4A):427-36. PubMed ID: 3050278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acceptor sites on chromatin for receptor bound by estrogen versus antiestrogen in antiestrogen-sensitive and -resistant MCF-7 cells.
    Singh RK; Ruh MF; Butler WB; Ruh TS
    Endocrinology; 1986 Mar; 118(3):1087-95. PubMed ID: 3948766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, characterization and biological evaluation of carboranylmethylbenzo[b]acridones as novel agents for boron neutron capture therapy.
    da Silva AF; Seixas RS; Silva AM; Coimbra J; Fernandes AC; Santos JP; Matos A; Rino J; Santos I; Marques F
    Org Biomol Chem; 2014 Jul; 12(28):5201-11. PubMed ID: 24915168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
    Pavlik EJ; Nelson K; Srinivasan S; Powell DE; Kenady DE; DePriest PD; Gallion HH; van Nagell JR
    Cancer Res; 1992 Aug; 52(15):4106-12. PubMed ID: 1638522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proton nuclear magnetic resonance measurement of p-boronophenylalanine (BPA): a therapeutic agent for boron neutron capture therapy.
    Zuo CS; Prasad PV; Busse P; Tang L; Zamenhof RG
    Med Phys; 1999 Jul; 26(7):1230-6. PubMed ID: 10435522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estrogen and antiestrogen binding to different forms of the molybdate-stabilized estrogen receptor.
    Ruh MF; Brzyski RG; Strange L; Ruh TS
    Endocrinology; 1983 Jun; 112(6):2203-5. PubMed ID: 6851947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Boron neutron capture therapy: linkage of a boronated macromolecule to monoclonal antibodies directed against tumor-associated antigens.
    Alam F; Soloway AH; Barth RF; Mafune N; Adams DM; Knoth WH
    J Med Chem; 1989 Oct; 32(10):2326-30. PubMed ID: 2795606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW; Martin J; Lynch M
    Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Boron neutron capture therapy of primary and metastatic brain tumors.
    Barth RF; Soloway AH
    Mol Chem Neuropathol; 1994; 21(2-3):139-54. PubMed ID: 8086033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo evaluation of carboranyl uridines as boron delivery agents for neutron capture therapy.
    Liu L; Barth RF; Tjarks W; Soloway AH; Anisuzzaman AK
    Anticancer Res; 1996; 16(1):113-20. PubMed ID: 8615595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular pharmacology of the D- and L-enantiomers of beta-5-o-carboranyl-2'-deoxyuridine.
    Hurwitz SJ; Ma L; Eleuteri A; Wright J; Moravek J; Schinazi RF
    Nucleosides Nucleotides Nucleic Acids; 2000 Mar; 19(3):691-702. PubMed ID: 10843501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular pharmacology and biological activity of 5-carboranyl-2'-deoxyuridine.
    Schinazi RF; Goudgaon NM; Fulcrand G; el Kattan Y; Lesnikowski Z; Ullas G; Moravek J; Liotta DC
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1113-20. PubMed ID: 8175396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.